TSMC Board Approves Capital Appropriation for 65nm and 90nm Capacity
TSMC Spokesperson and Vice President Ms. Lora Ho said other major conclusions of the Board meeting were as follows:
1. Approved capital appropriation of US$9.2 million to expand 1.0 micron high voltage process capacity in Fab 2.
2. Approved the purchase of an additional 6.8% of shares in Systems on Silicon Manufacturing Company Pte. Ltd. (SSMC) at a price of approximately US$73 million. TSMC will own 38.8% of SSMC after the purchase.
3. Approved capital increase of NT$24,828,340 to reflect the issuance of 2,482,834 new TSMC common shares as a result of employees exercising their stock options between July 1 and September 30, 2006. Subsequent to such capital increase, the registered paid-in capital of TSMC will be NT$258,258.4 million.
|
Related News
- TSMC Board of Directors Approves Capital Appropriation for Expanding Capacities
- TSMC Board Approves Expansion of 45 Nanometer Capacity
- ARM Announces The Release Of Multiple Standard Cell Libraries On TSMC 90nm and 65nm Processes
- Accellera Board Approves Universal Verification Methodology for Mixed-Signal (UVM-MS) 1.0 Standard for Release
- TSMC Announces Dr. Mark Liu Not to Participate in Next Board of Directors Election
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |